Qianxia Zhang

Qianxia Zhang

Auto-generated profile, based on publicly available information

Qianxia Zhang

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
DSDeepali V. Sawant
Deepali V. Sawant
HYHiroshi Yano
Hiroshi Yano
MCMaria Chikina
Maria Chikina
QZQianxia Zhang
Qianxia Zhang
MLMengting Liao
Mengting Liao
DVDario A. A. Vignali
Dario A. A. Vignali

1 May 2016 in Immunity
Verified
Journal Article
Closed access
QZQianxia Zhang
Qianxia Zhang
DVDario A.A. Vignali
Dario A.A. Vignali

6 October 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CTCatherine L. Tan
Catherine L. Tan
JKJuhi R. Kuchroo
Juhi R. Kuchroo
PSPeter T. Sage
Peter T. Sage
DLDan Liang
Dan Liang
LFLoise M. Francisco
Loise M. Francisco
ASArlene H. Sharpe
Arlene H. Sharpe
Inhibitory signals through the PD-1 pathway regulate T cell activation, T cell tolerance, and T cell exhaustion. Studies of PD-1 function have focused primarily on effector T cells. Far less is known about PD-1 function in regulatory T (T reg) cells. To study the role of PD-1 in T reg cells, we generated mice that selectively lack PD-1 in T reg cells. PD-1–deficient T reg cells exhibit an activated phenotype and enhanced immunosuppressive function. The in vivo significance of the potent suppressive capacity of PD-1–deficient T reg cells is illustrated by ameliorated experimental autoimmune encephalomyelitis (EAE) and protection from diabetes in nonobese diabetic (NOD) mice lacking PD-1 selectively in T reg cells. We identified reduced signaling through the PI3K–AKT pathway as a mechanism underlying the enhanced suppressive capacity of PD-1–deficient T reg cells. Our findings demonstrate that cell-intrinsic PD-1 restraint of T reg cells is a significant mechanism by which PD-1 inhibitory signals regulate T cell tolerance and autoimmunity.

31 March 2017 in Science Immunology
Verified
Journal Article
Closed access
PDF file
QZQianxia Zhang
Qianxia Zhang
MCMaria Chikina
Maria Chikina
ASAndrea L. Szymczak-Workman
Andrea L. Szymczak-Workman
WHWilliam Horne
William Horne
JKJay K. Kolls
Jay K. Kolls
DVDario A. A. Vignali
Dario A. A. Vignali
Inhibitory receptors (IRs) are pivotal in controlling T cell homeostasis because of their intrinsic regulation of conventional effector T (Tconv) cell proliferation, viability, and function. However, the role of IRs on regulatory T cells (Tregs) remains obscure because they could be required for suppressive activity and/or limit Treg function. We evaluated the role of lymphocyte activation gene 3 (LAG3; CD223) on Tregs by generating mice in which LAG3 is absent on the cell surface of Tregs in a murine model of type 1 diabetes. Unexpectedly, mice that lacked LAG3 expression on Tregs exhibited reduced autoimmune diabetes, consistent with enhanced Treg proliferation and function. Whereas the transcriptional landscape of peripheral wild-type (WT) and Lag3-deficient Tregs was largely comparable, substantial differences between intra-islet Tregs were evident and involved a subset of genes and pathways that promote Treg maintenance and function. Consistent with these observations, Lag3-deficient Tregs outcompeted WT Tregs in the islets but not in the periphery in cotransfer experiments because of enhanced interleukin-2–signal transducer and activator of transcription 5 signaling and increased Eos expression. Our study suggests that LAG3 intrinsically limits Treg proliferation and function at inflammatory sites, promotes autoimmunity in a chronic autoimmune-prone environment, and may contribute to Treg insufficiency in autoimmune disease.

1 January 2020 in Cell Reports
Verified
Journal Article
Open access
JSJeremy A. Sullivan
Jeremy A. Sullivan
YTYusuke Tomita
Yusuke Tomita
EJEwa Jankowska-Gan
Ewa Jankowska-Gan
DLDiego A. Lema
Diego A. Lema
MAMatt P. Arvedson
Matt P. Arvedson
WBWilliam J. Burlingham
William J. Burlingham
Interleukin-35 (IL-35) is an immunosuppressive cytokine composed of Epstein-Barr-virus-induced protein 3 (Ebi3) and IL-12α chain (p35) subunits, yet the forms that IL-35 assume and its role in peripheral tolerance remain elusive. We induce CBA-specific, IL-35-producing T regulatory (Treg) cells in TregEbi3WT C57BL/6 reporter mice and identify IL-35 producers by expression of Ebi3TdTom gene reporter plus Ebi3 and p35 proteins. Curiously, both subunits of IL-35 are displayed on the surface of tolerogen-specific Foxp3+ and Foxp3neg (iTr35) T cells. Furthermore, IL-35 producers, although rare, secrete Ebi3 and p35 on extracellular vesicles (EVs) targeting a 25- to 100-fold higher number of T and B lymphocytes, causing them to acquire surface IL-35. This surface IL-35 is absent when EV production is inhibited or if Ebi3 is genetically deleted in Treg cells. The unique ability of EVs to coat bystander lymphocytes with IL-35, promoting exhaustion in, and secondary suppression by, non-Treg cells identifies a novel mechanism of infectious tolerance.

26 May 2022 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SGStephanie Grebinoski
Stephanie Grebinoski
QZQianxia Zhang
Qianxia Zhang
ACAnthony R. Cillo
Anthony R. Cillo
SMSasikanth Manne
Sasikanth Manne
HXHanxi Xiao
Hanxi Xiao
DVDario A. A. Vignali
Dario A. A. Vignali